Large Volume Parenteral Market Size to Reach 18.64 billion by 2031, Driven by Rising Hospitalization and Intravenous Therapy Demand

Mordor Intelligence has published a new report on large volume parenteral market offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction to Large Volume Parenteral Market Size

The large volume parenteral market size was valued at USD 12.83 billion in 2026 and is projected to reach USD 18.64 billion by 2031, growing steadily over the forecast period according to Mordor Intelligence. Market expansion is supported by sustained demand for intravenous therapies in hospitals, rising hospitalization rates, and the continued reliance on parenteral nutrition and fluid replacement therapies in critical and long-term care. Large volume parenterals remain essential in managing dehydration, electrolyte imbalance, and drug delivery across acute and chronic conditions. Hospitals represent the primary end users, while long-term care facilities and specialty clinics continue to increase utilization. North America maintains a leading share of the large volume parenteral market, with Asia-Pacific showing consistent growth as healthcare access and hospital capacity expand.

Report Overview: https://www.mordorintelligence.com/industry-reports/large-volume-parenteral-market?utm_source=openpr

Large Volume Parenteral Market Trends & Forecast

The large volume parenteral market trends reflect evolving clinical practices, safety requirements, and hospital workflow needs worldwide:

Preference for Ready-to-Use Formulations
Healthcare providers are increasingly adopting premixed and ready-to-administer parenteral solutions to reduce preparation time, limit medication errors, and support standardized treatment protocols across care settings.

Shift Toward Flexible Packaging Formats
Flexible plastic infusion bags are increasingly favored over glass containers due to ease of handling, reduced breakage risk, and streamlined storage and transportation, supporting operational efficiency in hospitals.

Growing Role in Nutritional Support
Large volume parenterals play an important role in parenteral nutrition for patients unable to receive oral or enteral feeding, particularly in oncology, gastrointestinal disorders, and postoperative care, contributing to overall large volume parenteral market growth.

These trends underline how clinical reliability and operational efficiency continue to shape purchasing decisions across the large volume parenteral market.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/large-volume-parenteral-market?utm_source=openpr



Large Volume Parenteral Market Segmentation

A detailed large volume parenteral market analysis highlights segmentation by product type, application, end user, and geography:

By Volume
100-250 mL
250-500 mL
500-1,000 mL
1,000-2,000 mL
More Than 2,000 mL

By Application
Therapeutic Injections
Fluid-Balance Injections
Nutritious / Parenteral Nutrition Injections

By Type of Packaging
Bottles (Glass)
Flexible Bags (PVC, Non-PVC)

By Manufacturing Technology
Traditional Aseptic Fill-Finish
Blow-Fill-Seal (BFS)

By End User
Hospitals
Home-Care and Alternate Site Infusion
Ambulatory Surgical Centers

By Geography

North America: Holds a significant share supported by advanced healthcare infrastructure and high inpatient care demand

Europe: Maintains steady adoption within established public healthcare systems

Asia-Pacific: Continues to expand as hospital capacity and healthcare spending increase

South America and Middle East & Africa: Emerging regions driven by healthcare system development

This segmentation reflects the wide clinical applicability and recurring usage patterns within the large volume parenteral market.



Key Players in the Large Volume Parenteral Market Share

The large volume parenteral market share is characterized by established pharmaceutical manufacturers with strong sterile production capabilities and extensive hospital supply networks. Competition centers on consistent product availability, regulatory compliance, and long-term hospital contracts.

Key companies active in the large volume parenteral market include:

Pfizer, Inc

B. Braun SE

Baxter International

Otsuka Pharmaceutical Co.

Fresenius Kabi AG

These players focus on maintaining high manufacturing standards, ensuring uninterrupted supply, and strengthening distribution partnerships with hospitals and healthcare systems. Their strategies emphasize reliability and quality assurance, which remain central to purchasing decisions in the large volume parenteral market.

Industry related Reports:

Biguanides Market
The biguanides market was valued at USD 19.44 billion in 2025 and is estimated to grow from USD 19.87 billion in 2026 to reach USD 22.18 billion by 2031, registering a CAGR of 2.22%. Market growth is supported by the large global diabetic population, continued use of biguanides as first-line therapy, and their long-established safety and cost profile.
Report Overview: https://www.mordorintelligence.com/industry-reports/biguanides-market?utm_source=openpr

Dipeptide Peptidase-4 (DPP-4) Inhibitors Market
The Dipeptide Peptidase-4 inhibitors market size is estimated at USD 12.22 billion in 2026, growing from USD 11.91 billion in 2025 and projected to reach USD 13.91 billion by 2031 at a CAGR of 2.61%. Growth is driven by sustained demand for oral antidiabetic therapies, combination treatment use, and ongoing management of type 2 diabetes.
Report Overview: https://www.mordorintelligence.com/industry-reports/dipeptide-peptidase-4-inhibitors-market?utm_source=openpr

Antihypertensive Drugs Market
The antihypertensive drugs market size is estimated at USD 27.61 billion in 2026, increasing from USD 26.69 billion in 2025 and forecast to reach USD 32.72 billion by 2031 at a CAGR of 3.45%. Market expansion is supported by rising hypertension prevalence, aging populations, and long-term medication use for cardiovascular risk management.
Report Overview: https://www.mordorintelligence.com/industry-reports/anti-hypertensive-drugs?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.